 SAN CARLOS, Calif., Oct. 30, 2020 PRNewswire -- Natera, Inc. NASDAQ: NTRA, a pioneer and global leader in cell-free DNA cfDNA testing, applauds the recent International Society for Prenatal Diagnosis ISPD position statement recommending the use of cfDNA screening in twin... 